MSG Sports Subsidiaries, NY Knicks and Rangers, Amend Media Rights Deals with MSG Networks

Reuters
28 Jun
MSG Sports Subsidiaries, NY Knicks and Rangers, Amend Media Rights Deals with MSG Networks

New York Knicks, LLC and New York Rangers, LLC, both subsidiaries of Madison Square Garden Sports Corp., have amended their media rights agreements with MSG Networks Inc. subsidiaries. The agreements, effective as of January 1, 2025, include a 28% reduction in the annual rights fee for the New York Knicks and an 18% reduction for the New York Rangers. Additionally, the annual rights fee escalator has been eliminated for both teams. The contract expiration dates have been adjusted to the end of the 2028-29 season, with MSG Networks retaining a right of first refusal. Alongside these amendments, MSG Networks issued penny warrants to Madison Square Garden Sports Corp., allowing the company to acquire 19.9% equity in MSG Networks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madison Square Garden Sports Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-151354), on June 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10